— Know what they know.
Not Investment Advice

BBIXF OTC

Bonus Biogroup Ltd.
1W: +0.0% 1M: +0.0% 3M: -63.6% YTD: -50.0% 1Y: -42.9% 3Y: +33.3% 5Y: -60.0%
$0.04
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Sell · Power 42 · $46.7M mcap · 1.03B float · 0.0000% daily turnover · Short 81% of daily vol

Balance Sheet Trends

Total Assets
$23M -47.9% ▼
5Y CAGR: +27.3%
Total Liabilities
$16M +5.6% ▲
5Y CAGR: -4.5%
Shareholders Equity
$7M -76.3% ▼
Cash & Investments
$7M -47.0% ▼
5Y CAGR: +130.7%
Total Debt
$10M -8.7% ▼
5Y CAGR: +11.6%
Net Debt
$3M +287.4% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2020FY2021FY2022FY2023FY2024
— Assets —
Cash$16M$79M$54M$13M$7M
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$16M$79M$54M$13M$7M
Net Receivables$0$0$0$0$0
Inventory$0$0$0$0$0
Other Current Assets$410K$1M$505K$13M$92K
Total Current Assets$17M$81M$54M$26M$7M
Property, Plant & Equip.$6M$15M$20M$18M$16M
Goodwill & Intangibles$0$0$39K$23K$7K
Long-Term Investments$29K$8K$0$0$0
Other Non-Current Assets$29M$8M$368K$372K$375K
Total Non-Current Assets$35M$23M$20M$18M$16M
Total Assets$51M$104M$75M$45M$23M
— Liabilities —
Accounts Payable$2M$4M$2M$1M$1M
Short-Term Debt$0$0$0$0$0
Deferred Revenue$0$0$0$0$0
Other Current Liabilities$949K$1M$2M$2M$2M
Total Current Liabilities$16M$9M$8M$6M$8M
Long-Term Debt$0$0$0$0$0
Other Non-Current Liab.$0$0$0$0$0
Total Non-Current Liabilities$4M$11M$11M$10M$9M
Total Liabilities$21M$20M$18M$16M$16M
— Equity —
Common Stock$157M$297M$301M$303M$303M
Retained Earnings-$152M-$243M-$281M-$310M-$338M
Accumulated OCI$26M$30M$37K$36K$41M
Total Stockholders Equity$31M$84M$56M$29M$7M
Total Liabilities & Equity$51M$104M$75M$45M$23M
— Key Metrics —
Total Debt$5M$12M$12M$11M$10M
Net Debt-$11M-$67M-$42M-$2M$3M
Total Investments$29K$8K$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms